PBGENE-HBV, Precision Biosciences’ experimental gene-editing therapy for chronic hepatitis B, showed early evidence of eliminating and inactivating hepatitis B viral DNA as designed,…

Assembly Biosciences plans to develop its investigational oral treatment, ABI-6250, for people with primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC). The…

Today, I sat down to go over my upcoming summer doctor appointments because ’tis the season for my annual upper and lower gastrointestinal scopes and…